or Try an Advanced Search...

    Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 44.79 -0.91% -0.41
    SWTX closed up 5.24 percent on Wednesday, May 15, 2024, on 66 percent of normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical SWTX trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.91%
    Crossed Above 20 DMA Bullish -0.91%
    MACD Bullish Signal Line Cross Bullish -0.91%
    Stochastic Buy Signal Bullish -0.91%
    Gapped Up Strength -0.91%
    Up 3 Days in a Row Strength -0.91%
    Oversold Stochastic Weakness 4.28%
    Narrow Range Bar Range Contraction 8.11%
    Stochastic Reached Oversold Weakness 8.11%
    Inside Day Range Contraction 8.11%
    Older End-of-Day Signals for SWTX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 3 hours ago
    Up 1% about 4 hours ago
    60 Minute Opening Range Breakout about 5 hours ago
    2x Volume Pace about 6 hours ago
    1.5x Volume Pace about 6 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    SWTX Chart by TradingView
    Basic chart:

    Profile

    Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development

    Is SWTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
    May 5 SpringWorks Therapeutics, Inc. (SWTX) Q1 2024 Earnings Call Transcript
    May 5 SpringWorks Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
    May 3 Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation
    May 3 SpringWorks Therapeutics Inc (SWTX) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
    May 2 SpringWorks Therapeutics GAAP EPS of -$1.18, revenue of $21M
    May 2 SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
    May 1 SpringWorks Therapeutics Q1 2024 Earnings Preview
    Apr 25 SpringWorks Therapeutics: Newly Commercial Stage, Fully Valued Biotech Means Steer Clear
    Apr 24 SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    See more SWTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.92
    52 Week Low 18.0
    Average Volume 909,319
    200-Day Moving Average 35.38
    50-Day Moving Average 46.19
    20-Day Moving Average 43.94
    10-Day Moving Average 43.62
    Average True Range 2.56
    RSI (14) 52.38
    ADX 21.19
    +DI 21.40
    -DI 25.47
    Chandelier Exit (Long, 3 ATRs) 40.53
    Chandelier Exit (Short, 3 ATRs) 46.57
    Upper Bollinger Bands 47.83
    Lower Bollinger Band 40.04
    Percent B (%b) 0.66
    BandWidth 17.73
    MACD Line -0.63
    MACD Signal Line -0.64
    MACD Histogram 0.0046
    Fundamentals Value
    Market Cap 3.26 Billion
    Num Shares 72.1 Million
    EPS -4.87
    Price-to-Earnings (P/E) Ratio -9.28
    Price-to-Sales 74.50
    Price-to-Book 8.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 48.04
    Resistance 3 (R3) 47.90 46.83 47.56
    Resistance 2 (R2) 46.83 46.10 46.89 47.40
    Resistance 1 (R1) 46.01 45.66 46.42 46.15 47.25
    Pivot Point 44.94 44.94 45.14 45.00 44.94
    Support 1 (S1) 44.12 44.21 44.53 44.26 43.15
    Support 2 (S2) 43.05 43.77 43.11 43.00
    Support 3 (S3) 42.23 43.05 42.84
    Support 4 (S4) 42.37